During the past decade, Lasarettet Helsingborg conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lasarettet Helsingborg" #1 collaborator was "BUPA Foundation" with 1 trials as a collaborator and "NHS Health Technology Assessment Programme" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Lasarettet Helsingborg" are "Atrial Fibrillation" (1 trials), "Carotid Stenosis" (1 trials) and "Percutaneous Coronary Intervention" (1 trials). Many other conditions were trialed in "Lasarettet Helsingborg" in a lesser frequency.

Most popular intervention types in "Lasarettet Helsingborg" are "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aspirin" (1 trials), "CEA, CAS" (1 trials), "Clopidogrel or Ticagrelor" (1 trials), "Dabigatran Etexilate 110mg" (1 trials) and "Dabigatran Etexilate 150mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lasarettet Helsingborg" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Lasarettet Helsingborg". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Lasarettet Helsingborg, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Lasarettet Helsingborg, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".